Cancer Research Institute

Advancing cancer immunotherapy through research, collaboration and data-driven innovation. Creating a world #Immune2Cancer. Est. 1953.

[Cancer Research Institute @CancerResearch]

An incredible evening celebrating #CancerResearch! ✨

Last night, we gathered in NYC for our 2026 Annual Awards Gala to honor those advancing #cancerimmunotherapy, including Reed Jobs, Eric Vivier, DVM, PhD, and Joseph Sun, PhD.

Read the recap: https://t.co/WfwN9DMGWp

[Cancer Research Institute @CancerResearch]

Myelodysplastic syndromes (MDS) are rare blood cancers.

On #MDSAwarenessDay, we spotlight CRI Irvington Postdoctoral Fellow @MariaSirenko of @nyugrossman, who studies the link between inflammation and MDS.

Learn more: https://t.co/TFiEkEVAVB

#BloodCancer

[Cancer Research Institute @CancerResearch]

From California to New York, our team is wearing pink for a purpose! 💗

This #BreastCancerAwarenessMonth, we're proud to stand together, coast to coast, in support of everyone affected by breast cancer and the research that's bringing new hope to patients.

#WearItPinkDay

[Cancer Research Institute @CancerResearch]

Learn more about Dr. Chen's CRI-funded research: https://t.co/wnfawzrQE1

[Cancer Research Institute @CancerResearch]

CRI STAR Sidi Chen, PhD (@sidichen) of @YaleMed joins @sitcancer for a webinar on systems immunology and T cell memory, key to durable immunotherapy responses. 🧬

🕛 Tue., Oct. 27 | 12–1:30 p.m. ET

Register: https://t.co/RysJ4CtN2K

#CancerImmunotherapy #TCells

[OncoDaily IO @OncoDailyIO]

CRI-Funded Research and Scientific Presentations at SITC 2026 – Cancer Research Institute (CRI)

@CancerResearch

https://t.co/22rPCfXkjg

[Cancer Research Institute @CancerResearch]

During Estate Planning Week, learn how to take the first step toward making your wishes known and leaving a lasting impact on cancer research.

📖 Read more and access our free guide: https://t.co/sI2uVUC9dQ

#PlannedGiving #EstatePlanningAwarenessWeek

[Cancer Research Institute @CancerResearch]

When caught before it spreads, breast cancer has a 5-year survival rate of over 99%. Mammograms can find it before symptoms appear.

This #NationalMammographyDay, learn 7 screening facts: https://t.co/kmlWh7QXcQ

#BreastCancerAwareness

[Society for Immunotherapy of Cancer @sitcancer]

Looking forward to CRI William B. Coley Award Lecture!

See you in Phoenix!

[Cancer Research Institute @CancerResearch]

Heading to #SITC26 in Phoenix, Nov. 4–8? Don't miss CRI's William B. Coley Award Lecture featuring Éric Vivier, plus presentations from CRI-funded scientists advancing #cancerimmunotherapy.

Explore CRI at SITC: https://t.co/m3tNph2LiT

#CancerResearch @sitcancer

[Cancer Research Institute @CancerResearch]

We’re proud to celebrate our CEO, Alicia Zhou, PhD, named one of @OncoDaily’s 100 Influential #WomenInOncology for 2026! 🎉

Her leadership continues to advance CRI’s mission and champion innovative #cancerimmunotherapy research. https://t.co/cvoYLX0wyM

[Cancer Research Institute @CancerResearch]

First diagnosed with stage 0 breast cancer, Judy Perkins later faced stage 4 disease. After receiving tumor-infiltrating lymphocyte (TIL) therapy, she became cancer-free and remains disease-free nearly a decade later. https://t.co/TfEISGjtwZ

#MetastaticBreastCancerAwarenessDay

[Cancer Research Institute @CancerResearch]

New research from CRI Irvington Postdoctoral Fellow @vBarthet and his team at @MSKCancerCenter explores a targeted nanotherapy designed to reduce fibrosis and improve response to checkpoint #immunotherapy.

Published in @ScienceMagazine.

Learn more: https://t.co/8WM35cqWBo

[Cancer Research Institute @CancerResearch]

This #DAFDay, make a lasting impact on #cancerresearch.

By recommending a grant to CRI through your #DonorAdvisedFund, you can help advance innovative research and new discoveries in #cancerimmunotherapy.

Learn more: https://t.co/S7GZ8uJ9DO

[Cancer Research Institute @CancerResearch]

As the world celebrates the #NobelPrize, we're reflecting on CRI's history of recognizing groundbreaking science.

12 William B. Coley Award recipients have gone on to win the Nobel Prize.

Meet a few of these scientists and explore their impact. 👉

https://t.co/5YVMo5LOis

[Cancer Research Institute @CancerResearch]

This #BreastCancerAwarenessMonth, explore new treatment options, emerging research, and CRI-supported advances: https://t.co/cUAhdAb8PA

[Cancer Research Institute @CancerResearch]

@oncodaily Congratulations to our CEO, Alicia Zhou, PhD, on this well-deserved recognition! We’re proud to see her leadership and commitment to advancing cancer immunotherapy celebrated among so many inspiring women in oncology.

[OncoDaily @oncodaily]

Continuing a special OncoDaily tradition - 𝟭𝟬𝟬 𝗜𝗻𝗳𝗹𝘂𝗲𝗻𝘁𝗶𝗮𝗹 𝗪𝗼𝗺𝗲𝗻 𝗶𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 - we are proud to present the 6th part of our 2026 list, celebrating the next 10 remarkable women whose leadership and contributions are shaping the future of oncology 🚀

🪄Alicia Zhou, PhD (@ay_zhou) is the Chief Executive Officer of the Cancer Research Institute (@CancerResearch), where she leads efforts to accelerate lifesaving cancer immunotherapy research. A scientist and healthcare executive with experience in cancer research, precision medicine, and health innovation, she has strengthened CRI’s support for investigators pursuing bold and potentially transformative ideas.

In 2026, CRI committed a record $34.4 million through 93 awards – the largest annual grantmaking total in its history – supporting scientists at 50 institutions across five countries. Through this investment, Zhou is helping sustain the research ecosystem behind the next generation of cancer immunotherapies.

Read the 6th part below.
🔗https://t.co/y0OVZmwXTa

#Oncology #OncoDaily100 #OncoDaily #Cancer #100InfluentialWomen #WomenInOncology

[Cancer Research Institute @CancerResearch]

Meet Reuven Agami, PhD, who is leading the CRI-supported @CancerGrand ILLUMINE team into the "dark proteome," a largely unexplored part of cancer biology.

Their goal: new targets for #immunotherapy in hard-to-treat cancers. https://t.co/GCSXRMVt9y

[Cancer Research Institute @CancerResearch]

When LaToya was diagnosed with #breastcancer, she was not offered #immunotherapy as an initial treatment option. After conducting her own research, she enrolled in a lifesaving clinical trial.

Hear her story: https://t.co/zYo1X29VUi

#BreastCancerAwarenessMonth